| |
Phase II Trial of Weekly Bortezomib in Combination With Rituximab in Relapsed or Relapsed and Refractory Waldenström Macroglobulinemia
3/10/2010
By IM Ghobrial, F Hong, S Padmanabhan, A Badros, M Rourke, R Leduc, S Chuma, J Kunsman, D Warren, B Harris, A Sam, KC Anderson, P Richardson, SP Treon, E Weller, J Matous
Publisher: Journal of Clinical Oncology
Please see attachment
View Attachment
<< Back
|
|
